查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552642

黑色素瘤治疗市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Melanoma Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 156 Pages | 商品交期: 2-10个工作天内

价格

黑色素瘤治疗市场 - 报告范围

TMR 关于全球黑色素瘤治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。年期间，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球黑色素瘤治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解黑色素瘤治疗市场。

市场概况
2023年市场价值 64 亿美元
2034 年市场价值 192 亿美元
复合年增长率 10.6%

该报告深入探讨了全球黑色素瘤治疗市场的竞争格局。全球黑色素瘤治疗市场的主要参与者已经确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球黑色素瘤治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依治疗类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依治疗类型，2020-2034
    • 化疗
    • 免疫治疗
    • 标靶治疗
    • 放射治疗
    • 手术
  • 市场吸引力分析：按治疗类型

第 7 章：全球市场分析与预测：按疾病适应症

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依疾病适应症，2020-2034
    • 表浅扩散黑色素瘤
    • 结节性黑色素瘤
    • 恶性雀斑样痣 黑色素瘤
    • 肢端雀斑样黑色素瘤
    • 促纤维增生性黑色素瘤
  • 市场吸引力分析：按疾病适应症

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 医院和专科诊所
    • 家庭护理设置
    • 其他（学术机构等）
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Bristol-Myers Squibb Company
    • AstraZeneca plc
    • Novartis AG
    • Merck & Co., Inc.
    • Amgen Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
Product Code: TMRGL80829

Melanoma Therapeutics Market - Scope of Report

TMR's report on the global melanoma therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global melanoma therapeutics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global melanoma therapeutics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the melanoma therapeutics market.

Market Snapshot
Market Value in 2023US$ 6.4 Bn
Market Value in 2034US$ 19.2 Bn
CAGR10.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global melanoma therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global melanoma therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global melanoma therapeutics market.

The report delves into the competitive landscape of the global melanoma therapeutics market. Key players operating in the global melanoma therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global melanoma therapeutics market profiled in this report.

Key Questions Answered in Global melanoma therapeutics Market Report:

  • What is the sales/revenue generated by melanoma therapeutics across all regions during the forecast period?
  • What are the opportunities in the global melanoma therapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Melanoma Therapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global melanoma therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global melanoma therapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global melanoma therapeutics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Melanoma Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Melanoma Therapeutics Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Melanoma Therapeutics Market Analysis and Forecast, by Therapy Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 6.3.1. Chemotherapy
    • 6.3.2. Immunotherapy
    • 6.3.3. Targeted Therapy
    • 6.3.4. Radiation Therapy
    • 6.3.5. Surgery
  • 6.4. Market Attractiveness Analysis, by Therapy Type

7. Global Melanoma Therapeutics Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2020-2034
    • 7.3.1. Superficial Spreading Melanoma
    • 7.3.2. Nodular Melanoma
    • 7.3.3. Lentigo Maligna Melanoma
    • 7.3.4. Acral Lentiginous Melanoma
    • 7.3.5. Desmoplastic Melanoma
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Melanoma Therapeutics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Homecare Settings
    • 8.3.3. Others (Academic Institutes, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Melanoma Therapeutics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Melanoma Therapeutics Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 10.3.1. Chemotherapy
    • 10.3.2. Immunotherapy
    • 10.3.3. Targeted Therapy
    • 10.3.4. Radiation Therapy
    • 10.3.5. Surgery
  • 10.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 10.4.1. Superficial Spreading Melanoma
    • 10.4.2. Nodular Melanoma
    • 10.4.3. Lentigo Maligna Melanoma
    • 10.4.4. Acral Lentiginous Melanoma
    • 10.4.5. Desmoplastic Melanoma
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals & Specialty Clinics
    • 10.5.2. Homecare Settings
    • 10.5.3. Others (Academic Institutes, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Therapy Type
    • 10.7.2. By Disease Indication
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Melanoma Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 11.3.1. Chemotherapy
    • 11.3.2. Immunotherapy
    • 11.3.3. Targeted Therapy
    • 11.3.4. Radiation Therapy
    • 11.3.5. Surgery
  • 11.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 11.4.1. Superficial Spreading Melanoma
    • 11.4.2. Nodular Melanoma
    • 11.4.3. Lentigo Maligna Melanoma
    • 11.4.4. Acral Lentiginous Melanoma
    • 11.4.5. Desmoplastic Melanoma
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals & Specialty Clinics
    • 11.5.2. Homecare Settings
    • 11.5.3. Others (Academic Institutes, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Therapy Type
    • 11.7.2. By Disease Indication
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Melanoma Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 12.3.1. Chemotherapy
    • 12.3.2. Immunotherapy
    • 12.3.3. Targeted Therapy
    • 12.3.4. Radiation Therapy
    • 12.3.5. Surgery
  • 12.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 12.4.1. Superficial Spreading Melanoma
    • 12.4.2. Nodular Melanoma
    • 12.4.3. Lentigo Maligna Melanoma
    • 12.4.4. Acral Lentiginous Melanoma
    • 12.4.5. Desmoplastic Melanoma
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals & Specialty Clinics
    • 12.5.2. Homecare Settings
    • 12.5.3. Others (Academic Institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Therapy Type
    • 12.7.2. By Disease Indication
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Melanoma Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 13.3.1. Chemotherapy
    • 13.3.2. Immunotherapy
    • 13.3.3. Targeted Therapy
    • 13.3.4. Radiation Therapy
    • 13.3.5. Surgery
  • 13.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 13.4.1. Superficial Spreading Melanoma
    • 13.4.2. Nodular Melanoma
    • 13.4.3. Lentigo Maligna Melanoma
    • 13.4.4. Acral Lentiginous Melanoma
    • 13.4.5. Desmoplastic Melanoma
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals & Specialty Clinics
    • 13.5.2. Homecare Settings
    • 13.5.3. Others (Academic Institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Therapy Type
    • 13.7.2. By Disease Indication
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Melanoma Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Therapy Type, 2020-2034
    • 14.3.1. Chemotherapy
    • 14.3.2. Immunotherapy
    • 14.3.3. Targeted Therapy
    • 14.3.4. Radiation Therapy
    • 14.3.5. Surgery
  • 14.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 14.4.1. Superficial Spreading Melanoma
    • 14.4.2. Nodular Melanoma
    • 14.4.3. Lentigo Maligna Melanoma
    • 14.4.4. Acral Lentiginous Melanoma
    • 14.4.5. Desmoplastic Melanoma
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals & Specialty Clinics
    • 14.5.2. Homecare Settings
    • 14.5.3. Others (Academic Institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Therapy Type
    • 14.7.2. By Disease Indication
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Bristol-Myers Squibb Company
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. AstraZeneca plc
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Merck & Co., Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Amgen Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. F. Hoffmann-La Roche AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Abbott Laboratories
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview

List of Tables

  • Table 01: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 02: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 03: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 07: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 08: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 11: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 12: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 15: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 16: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 19: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 20: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
  • Table 23: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 24: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Melanoma Therapeutics Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Melanoma Therapeutics Market Revenue (US$ Bn), by Therapy Type, 2023
  • Figure 03: Global Melanoma Therapeutics Market Value Share, by Therapy Type, 2023
  • Figure 04: Global Melanoma Therapeutics Market Revenue (US$ Bn), by Disease Indication, 2023
  • Figure 05: Global Melanoma Therapeutics Market Value Share, by Disease Indication, 2023
  • Figure 06: Global Melanoma Therapeutics Market Revenue (US$ Bn), by End-user, 2023
  • Figure 07: Global Melanoma Therapeutics Market Value Share, by End-user, 2023
  • Figure 08: Global Melanoma Therapeutics Market Value Share, by Region, 2023
  • Figure 09: Global Melanoma Therapeutics Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 11: Global Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 13: Global Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 14: Global Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Melanoma Therapeutics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Melanoma Therapeutics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Melanoma Therapeutics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 22: North America Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 23: North America Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 26:North America Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 31: Europe Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 32: Europe Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 35: Europe Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 40: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 41: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 44: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 49: Latin America Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 50: Latin America Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 53: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
  • Figure 58: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 59: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 62: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034